Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines01:30

Cancer Vaccines

884
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
884
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic, epitranscriptomic, and metabolic control of T cell exhaustion.

Trends in cancer·2026
Same author

Immune Profiling Identifies High-Risk Neutrophil-Rich Subtype in Checkpoint Inhibitor Nephritis.

Kidney international reports·2026
Same author

CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

Science translational medicine·2025
Same author

Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.

Cancer discovery·2025
Same author

Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC.

JTO clinical and research reports·2025
Same author

Ablation of FAS confers allogeneic CD3<sup>-</sup> CAR T cells with resistance to rejection by T cells and natural killer cells.

Nature biomedical engineering·2024

Related Experiment Video

Updated: Dec 30, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.3K

Methods to edit T cells for cancer immunotherapy.

Francesca Lucibello1, Silvia Menegatti1, Laurie Menger1

  • 1INSERM U932, PSL University, Institut Curie, Paris, France.

Methods in Enzymology
|January 18, 2020
PubMed
Summary

Gene-editing technologies are advancing adoptive T cell immunotherapy for cancer. These innovations create programmable T cells with long-term potential to fight tumors, particularly CAR-T cells generated via lentiviral transfer.

Keywords:
Adoptive transferCancer immunotherapyT cells engineering

More Related Videos

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

822
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

Related Experiment Videos

Last Updated: Dec 30, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.3K
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

822
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

Area of Science:

  • Immunology
  • Gene Therapy
  • Oncology

Background:

  • Adoptive T cell immunotherapy is a promising cancer treatment.
  • Gene-editing technologies offer new ways to enhance T cell function.
  • Current methods focus on improving T cell specificity and persistence.

Purpose of the Study:

  • To summarize recent advancements in gene-editing for T cell immunotherapy.
  • To highlight strategies for creating programmable and inducible T cells.
  • To review optimized protocols for CAR-T cell generation.

Main Methods:

  • Review of gene-editing technologies (e.g., CRISPR-Cas9).
  • Discussion of lentiviral gene transfer for T cell modification.
  • Analysis of strategies for T cell programming and induction.

Main Results:

  • Gene editing enables tailored T cells with redirected specificity.
  • Engineered T cells demonstrate programmable and inducible antitumor potential.
  • Optimized protocols facilitate efficient CAR-T cell generation.

Conclusions:

  • Gene-editing technologies are revolutionizing T cell immunotherapy.
  • Programmable T cells offer enhanced and sustained antitumor activity.
  • Lentiviral-mediated CAR-T cell generation is a key strategy.